Can Functional Neurological Disorder Improve? Prognosis and Recovery
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Functional neurological disorder (FND) can improve, sometimes substantially. People may recover an activity they had lost, experience fewer seizures or movements, return to school or work, and regain confidence in daily life. Some achieve remission. Others continue to have symptoms, including disabling symptoms, over several years. A realistic prognosis considers the particular symptom type, duration, accompanying health conditions, access to appropriate treatment, and changes in everyday functioning.
FND describes genuine neurological symptoms involving altered control or functioning of the nervous system. Common presentations include functional limb weakness, tremor, gait disturbance, functional seizures (also called psychogenic nonepileptic seizures or PNES), speech symptoms, sensory changes, and cognitive complaints. Diagnosis is made through an appropriate clinical history and examination, including positive signs of internal inconsistency or incongruence where applicable. FND is not evidence of deliberate deception. It can coexist with epilepsy, neurological disease, chronic pain, fatigue, or psychiatric conditions. A clinical review of FND diagnosis and management explains the contemporary rule-in approach.
The answer to “Will I recover?” therefore begins with two clinically useful questions: Which manifestations of FND are present, and what does recovery mean for this individual? Research is increasingly informative at the group level. No currently established single test can predict a person's individual recovery.
What does recovery from FND mean?
Recovery is broader than having a symptom disappear on one particular day. Clinical studies distinguish full remission, partial improvement, stable symptoms, recurrence, and deterioration. A person can have fewer attacks while still experiencing fatigue or disability. Another person can return to meaningful activities despite persistent intermittent symptoms. Both outcomes may represent important progress, but they describe different results.
Clinicians and patients may track symptom burden, physical function, cognitive and emotional well-being, social participation, quality of life, and health care use. In motor FND, measures can include safe walking, limb use, transfers, balance, endurance, and independence. In functional seizures, they may include event frequency, injuries, ability to recognize warning signs, participation, and seizure-related distress. A meaningful treatment plan identifies priorities together and reassesses them over time.
This distinction matters in research. The 2025 systematic review of prognostic indicators emphasizes that a change in seizure frequency does not necessarily translate into restored participation in life roles. Its findings support measuring both symptom change and real-world function.
What do long-term outcome studies show?
The evidence supports meaningful potential for improvement, alongside a substantial burden of persistent symptoms, especially in adult motor FND and functional seizures. Estimates vary widely because studies recruit different populations, follow people for different lengths of time, use different definitions of recovery, and frequently include participants who received different kinds of care.
A 2014 systematic review of functional motor symptoms included 24 follow-up studies. The authors found considerable variation, with an average weighted follow-up of 7.4 years among the studies for which it could be calculated. Across studies contributing to one pooled descriptive measure, an average 39% were reported as having the same or worse symptoms at follow-up, although the range across studies was 10%–90%. This descriptive figure is not an individual's probability of recovery and should not be applied across all FND subtypes.
A 2026 subtype-specific prognosis review similarly reported frequent persistent symptoms and functional impairment in adults with motor FND or functional seizures, with complete remission uncommon in many long-term cohorts. The authors found more favorable symptom outcomes in some sensory-only and functional visual presentations, but those comparisons rested on smaller and heterogeneous evidence bases. Pediatric cohorts often showed better symptom outcomes than adult cohorts, although ongoing psychosocial difficulties were reported.
These studies describe the course of patients encountered in particular clinical settings. They are not proof that treatment is ineffective, that everyone develops chronic disability, or that a patient with a long history of FND cannot improve. Severe referral populations, retrospective designs, different diagnostic eras, loss to follow-up, and inconsistent outcome definitions restrict the precision of any universal forecast.
Can FND improve after months or years?
Yes. Longer symptom duration has been associated with less favorable outcomes in several studies, and earlier diagnosis and treatment are reasonable clinical priorities. However, duration is a prognostic association, not a biological deadline. Improvement after years of symptoms is possible, and the literature does not establish a point beyond which recovery becomes impossible.
There is also a scientific disagreement about how strongly duration independently predicts outcome. The 2026 prognosis synthesis identified longer duration before diagnosis as its most consistent adverse prognostic factor. By contrast, a 2025 review of 30 studies did not identify illness duration as consistently related to its assessed outcomes. Different participant groups, outcomes, and analytical methods are plausible explanations for the discrepancy. The correct interpretation is that prompt, appropriate care matters, while an individual prediction requires broader assessment.
Symptoms may improve gradually, fluctuate, resolve for a period, or return under changing circumstances. A setback after progress should prompt an examination of what has changed: activity load, illness, pain, sleep, medication, life demands, treatment fit, or the emergence of another health problem. Recurrence itself is not proof that progress was illusory.
Does prognosis differ between types of FND?
Functional motor symptoms: weakness, tremor, gait, and dystonia
Motor FND can affect walking, posture, limb strength, tremor, and coordination. Targeted rehabilitation frequently emphasizes retraining automatic movement, modifying unhelpful patterns of attention to movement, improving function through graded practice, and supporting activity outside sessions. Individual symptom types, severity, pain, fatigue, mobility aids, and other diagnoses can influence what is feasible.
Motor outcome data are especially important because many intervention studies concern this subtype. The 2024 Physio4FMD randomized trial compared specialist FND physiotherapy with usual community neurological physiotherapy. At 12 months, the study did not find a significant between-group benefit on its primary self-reported physical-functioning measure. More participants receiving specialist therapy reported improvement in motor symptoms, and some secondary outcomes favored specialist care. These findings support physiotherapy as an option while limiting claims that one specific protocol always outperforms appropriate usual care.
Functional tremor or weakness may improve in one activity before another. Progress in smooth walking, safer transfers, or daily tasks may appear before a complete reduction in symptom severity. A rehabilitation program should record these practical gains without demanding that every symptom resolve simultaneously.
Functional seizures (PNES)
Functional seizures are episodes of altered behavior, awareness, movement, or sensation that resemble epileptic seizures but have a different mechanism. Epilepsy and functional seizures can occur in the same person, so an individualized neurological assessment remains essential. Video-EEG recording of typical events is often helpful where feasible.
The American Academy of Neurology's 2026 practice guideline concludes that psychological interventions are possibly effective for achieving freedom from functional seizures, reducing event frequency and anxiety, and improving psychosocial outcomes. The evidence is based on a limited number of studies with varying quality, and the guideline encourages evaluation for coexisting epilepsy and psychiatric conditions.
A major randomized study, the CODES trial, found no statistically significant difference in its primary measure of monthly seizure frequency at 12 months when specialized cognitive behavioral therapy plus standardized medical care was compared with standardized medical care alone. Several secondary outcomes, including psychosocial functioning and the longest seizure-free interval, favored the CBT group. This is a valuable reminder that treatment benefits may be clinically important even when the primary event-count outcome is unchanged.
Antiseizure medications should never be stopped or changed independently. A treating clinician should review what each medicine is treating, especially when epilepsy also exists. Medication decisions must follow the patient's full diagnostic picture and current specialist guidance.
Sensory, visual, speech, and cognitive symptoms
Functional changes in sensation, vision, speech, voice, or cognition require assessment tailored to the complaint. Available follow-up data suggest that some sensory and visual presentations may have better symptom outcomes than certain motor or seizure presentations, but evidence is less extensive. Speech-language therapy or tailored rehabilitation may be considered after specialist assessment. Persistent memory or attention complaints merit appropriate neurological and cognitive evaluation, including consideration of other conditions.
A broad label such as “FND recovery rate” conceals these differences. Prognosis should be explained with the diagnosed phenotype in mind, rather than importing percentages from a study of a different subtype.
Which factors may influence recovery?
Timely diagnosis and clear explanation
A timely, well-supported diagnosis makes it possible to discuss appropriate treatment earlier. The explanation should describe the positive clinical findings supporting FND, recognize that symptoms are real, and explain how follow-up will address new concerns. Delayed recognition can prolong uncertainty and may lead to repeated ineffective interventions.
Diagnostic communication also influences trust and the treatment relationship. It is reasonable for patients to ask which examination findings established the diagnosis, whether additional conditions have been considered, and which new symptoms would require reevaluation. An FND diagnosis does not end routine preventive care or remove the need to investigate new red flags.
Access to treatment that fits the symptoms
The choice of treatment depends on what is impairing life. A person with prominent gait symptoms may benefit from neurological physiotherapy; another with functional seizures may need a psychotherapy pathway and seizure-safety planning; someone unable to manage household tasks may require occupational therapy. Coordinated care can address several domains together.
A 2026 systematic review and meta-analysis of rehabilitation trials included 30 articles with 1,581 participants and estimated clinical improvement in 74% of participants receiving rehabilitation within the included studies. This is a pooled proportion drawn from selected intervention populations, not an all-patient cure rate or a guarantee for an individual. Outcomes were heterogeneous. The randomized-trial analyses showed improvement in FND symptoms but did not demonstrate statistically significant effects across every other measured domain, such as physical function, fatigue, or mental health.
Coexisting conditions, pain, and fatigue
Chronic pain, fatigue, poor sleep, migraine, anxiety, depression, epilepsy, and other medical or psychological conditions may complicate day-to-day recovery and treatment planning. Coexisting conditions require their own assessment and care. A person can simultaneously have FND and another neurological diagnosis. Treating a sleep disorder or depression may help overall function without establishing either as the cause of FND.
Associations between psychological characteristics and outcomes must be interpreted carefully. The 2025 biopsychosocial prognosis review reported associations involving previous psychiatric treatment, somatization and alexithymia, but findings do not establish that any characteristic directly causes FND or determines an individual's future.
Participation, resources, and life circumstances
Workforce participation was associated with better outcomes in the 2025 prognostic review. That association should not be read as evidence that employment itself cures FND or that unemployment reflects unwillingness to recover. Physical capacity, workplace accommodations, income security, insurance, transportation, family responsibilities, and access to specialists may influence both participation and health.
A recovery plan should include meaningful roles where feasible, such as education, work, parenting, relationships, recreation, or self-care. Occupational therapy and individualized accommodations can help align activity demands with current capacity. The social context is part of clinical care and research, rather than a measure of patient motivation.
Beliefs, expectations, and perceived control
A 2025 prognostic analysis of Physio4FMD found that greater perceived control over recovery predicted some self-reported improvements, while stronger beliefs in symptom permanence predicted less improvement on some measures. Such statistical relationships do not imply that patients produce symptoms by thinking about them or that optimism is a substitute for treatment. Attitudes may shift through experience, education, supportive care, and successful activity practice.
No single feature reliably predicts the outcome of every person with FND. The most useful approach combines clinical history, a clear positive diagnosis, evaluation of coexisting conditions, careful rehabilitation goals, and repeated observation of function.
Which treatments can support improvement?
Specialist physiotherapy and motor retraining
Physiotherapy for functional motor symptoms often uses a different emphasis from approaches intended solely for weakness caused by muscle or nerve damage. Clinicians may practice movements that occur more automatically, redirect excessive conscious monitoring of motor performance, rebuild safe activity, and help translate successful movements into daily tasks.
The international physiotherapy consensus recommendations describe patient education, movement retraining, and self-management within a collaborative rehabilitation framework. These recommendations are clinical consensus informed by evidence and specialist practice; they do not provide a fixed number of sessions or a guaranteed response rate.
In practice, plans should consider physical safety, endurance, falls risk, pain, and other diagnoses. Rehabilitation that triggers intolerable symptom exacerbation may need modification. Progress usually becomes more sustainable when practiced across environments and reinforced by a shared clinical explanation.
Psychological therapy when indicated
Psychological treatments can help some patients work with functional seizures, distress, coping patterns, avoidance, emotional regulation, or coexisting psychiatric symptoms. Cognitive behavioral approaches have the most relevant trial evidence in some functional seizure populations. Therapeutic work should be chosen according to the person's needs, preferences, and the actual intervention studied.
Psychotherapy should not be portrayed as proof that symptoms are imagined. Likewise, a trauma-focused intervention is appropriate when clinically indicated by a trauma-related presentation, rather than being imposed as a required explanation for FND. Exposure to traumatic experiences is neither a universal cause nor a diagnostic requirement.
Occupational therapy, communication therapy, and coordinated care
Occupational therapists can address self-care, routines, environmental adaptation, graded return to activities, and functional goals. The occupational therapy consensus paper emphasizes education, functional activity, and self-management strategies. Speech-language therapy may support selected functional speech, swallowing, or voice symptoms after suitable assessment.
Team communication matters. Conflicting explanations and disconnected referrals may prolong uncertainty, while a shared plan can clarify who is responsible for diagnosis, medication review, symptom-specific rehabilitation, mental health assessment, and follow-up. Access to a specialized FND service may help, but care can also be coordinated among knowledgeable local clinicians.
Medication and procedures
No medication has been established as a universal cure for FND itself. Medicines may be appropriate for a separately diagnosed condition such as migraine, depression, anxiety, or epilepsy. A clinician should assess benefits, side effects, and potential interactions. Proposed neuromodulation and other specialized interventions remain areas of research, with variable evidence across protocols.
A 2025 umbrella review of FND treatments found encouraging signals for tailored psychotherapy and physiotherapy, with heterogeneous evidence and methodological limitations. It also described inconsistent results for neuromodulation. The quality of available studies does not support treating every promising technique as an established intervention.
How long does FND recovery take?
There is no evidence-based universal timetable. An individual may improve over weeks or months, require a longer course of rehabilitation, or experience chronic or relapsing symptoms. Recovery time depends on which outcomes are tracked, and published studies differ in follow-up duration.
A treatment schedule is also not the same as the full period of recovery. In Physio4FMD, clinical outcomes were assessed 12 months after randomization even though the specialist treatment itself comprised a limited series of sessions and follow-up. A clinician may evaluate changes repeatedly after a program ends.
For a useful follow-up plan, ask which abilities should improve first, how these will be measured, how fatigue and pain will be managed, what to do if progress plateaus, and when the diagnosis and treatment approach should be reviewed. Monitoring function over time is more informative than comparing yourself with an advertised “average recovery time.”
What does a practical recovery plan look like?
An individualized plan typically begins by confirming the diagnosis and recording a few priorities. For example, walking safely to a nearby destination, returning to part-time study, managing daily activities more independently, or reducing the disruption caused by functional seizures can be defined as observable goals. The clinical team may use validated symptom, participation, and quality-of-life measures alongside patient-defined priorities.
Next, treatment is matched to the symptom profile and delivered at a tolerable pace. Physical or occupational therapy exercises are practiced as advised, with realistic opportunities to use new skills in daily life. If functional seizures are present, patients and families receive a safety plan and appropriate specialist follow-up. Pain, fatigue, sleep, and other disorders are treated according to their own clinical indications.
Finally, appointments review progress, barriers, accommodations, and new symptoms. If the existing program is not helping, the response is reassessment: verify that the diagnosis remains well supported, revisit goals and coexisting conditions, consider a different therapy approach or level of support, and address obstacles to care. No person should be judged on the speed or completeness of improvement.
What if symptoms get worse again?
Fluctuations and relapses can occur. Temporary worsening may coincide with illness, sleep disruption, pain, excessive exertion, medication changes, or substantial life demands, but no trigger needs to be identified in every episode. A clinician can help distinguish recurrence of familiar functional symptoms from new symptoms needing investigation.
When previously learned rehabilitation strategies remain appropriate, clinicians may adapt them and re-establish manageable routines. Relapse planning can identify when to contact the treating team, how to maintain safety, and what changes should prompt a new medical examination. It is appropriate to revise a rehabilitation plan without assigning blame.
Importantly, sudden facial droop, new one-sided weakness, new inability to speak, first or markedly different seizure-like episodes, severe new headache, fainting with concerning features, chest pain, significant injury, or rapidly evolving neurological symptoms require timely medical assessment or emergency care as appropriate. A known FND diagnosis must not be used to dismiss potentially urgent new illness.
Can children and teenagers recover from FND?
Many pediatric patients show substantial improvement, particularly when the diagnosis is communicated clearly and family-centered care is organized promptly. Nevertheless, a child's outcome depends on symptoms, developmental context, school functioning, coexisting conditions, and the treatments available. Published success rates vary substantially across programs and should not be presented as universal.
A 2025 pediatric cohort study investigated clinical characteristics and prognosis in childhood FND. A broader 2026 prognosis synthesis found generally better symptom outcomes in pediatric cohorts than adult cohorts, while noting that psychosocial consequences can persist.
Treatment may involve pediatric neurology, primary care, psychology, physiotherapy, school staff, and caregivers. Plans often address sleep, developmentally suitable activity, gradual school reintegration, family communication, and protection from unnecessary disability. Children still require evaluation for neurological and medical alternatives, and symptoms must be taken seriously even when examinations support an FND diagnosis.
Can FND coexist with another neurological or medical condition?
Yes. FND may coexist with epilepsy, migraine, movement disorders, chronic pain, and other health conditions. Clinicians should assess each presentation in context and investigate when the history, examination, or change in symptoms warrants it. A positive clinical sign can help establish a functional component, but cannot exclude every other disease.
For functional seizures, the AAN guideline specifically recommends evaluation for coexisting epilepsy. For motor symptoms, accurate characterization of positive findings and appropriate neurological assessment support diagnosis and targeted rehabilitation. Clinical uncertainty should be named and followed, rather than hidden behind a global label.
How should prognosis be discussed with a clinician?
A helpful prognosis conversation explains what the diagnosis means, which signs support it, what treatment is available, and how improvement will be assessed. It acknowledges the range of possible outcomes and avoids predictions based on a single factor. Clinicians may distinguish symptom improvement, return of abilities, reduced disability, and remission because each matters differently.
Patients can ask: What changes are realistic to monitor over the next few visits? Which therapy is suited to this symptom? How will other conditions be managed? What should happen if the current approach does not work? Which symptoms would require urgent reassessment? What support is available for work, school, caregiving, or disability accommodations?
If a person has persistent disability, management still matters. Symptom-directed treatment, prevention of injuries and medication complications, mobility support, community services, psychological care when indicated, and practical accommodations remain meaningful outcomes even when complete remission is not achieved.
What remains uncertain in the science of FND recovery?
Important evidence gaps include limited long-term controlled studies, inconsistent definitions of remission and functional recovery, underrepresentation of people outside tertiary clinics, uneven access to specialized services, and incomplete evaluation of social and structural barriers. Pediatric and adult results should not be pooled indiscriminately. Seizure and motor treatment data should not be generalized to functional visual, speech, or cognitive symptoms without supporting studies.
Interpretation also requires distinguishing prediction from causation. A factor associated with outcome may reflect baseline severity, access to care, social support, or unmeasured variables. Post hoc subgroup findings can generate hypotheses but require replication. Biomarkers and mechanism models are not yet established as individual prognostic tests.
The 2026 rehabilitation meta-analysis illustrates both progress and limitations: many participants reported improvement, but heterogeneity and the small number of randomized trials restrict confidence in universal effect estimates. Evidence-based communication should remain precise about what is known for each FND subtype and intervention.
Frequently asked questions
Is FND curable?
Some people achieve complete symptom remission; others recover important abilities or experience partial improvement while symptoms persist. “Cure” is not a consistently defined outcome across studies. The clinical goal should reflect both symptoms and real-life functioning.
Can FND go away without treatment?
Spontaneous or treatment-independent improvement can occur, but its frequency is difficult to isolate because long-term studies differ in care exposure and follow-up. The possibility of spontaneous improvement should not delay proper diagnosis or access to symptom-specific rehabilitation.
Does having FND for five or ten years mean recovery is impossible?
No. Longer duration is associated with less favorable outcomes in some analyses, but studies disagree about how consistently it predicts outcome, and it provides no individual cutoff. Assessment and appropriate treatment remain worthwhile regardless of illness duration.
Is full recovery more common in children?
Pediatric cohorts frequently report more favorable symptom outcomes than adult cohorts, according to recent syntheses. Results depend on referral setting, severity, treatment model, and definitions of recovery. Emotional, educational, or social difficulties may need ongoing attention even after physical symptoms improve.
Do functional seizures ever stop completely?
Yes, some patients achieve seizure freedom. The likelihood varies, and psychological interventions have evidence of possible benefit. Follow-up should include quality of life, functioning, seizure safety, and reassessment for epilepsy when indicated.
Will physiotherapy make FND worse?
Appropriate FND-informed physiotherapy is generally intended to improve function through individualized retraining. Some activities may transiently increase symptoms or fatigue, requiring adjustment. A treatment plan should incorporate safety, pacing, coexisting illnesses, and regular review; substantial new symptoms deserve medical assessment.
Does relapse mean rehabilitation has failed?
No. Recurrence may require an adjusted plan, additional support, or investigation of a new health issue. Recovery is often monitored over time rather than defined by one symptom-free interval.
Is trauma therapy required for recovery?
Trauma-focused therapy is useful when a relevant trauma-related condition or clinical need is present. Trauma is not a universal prerequisite for FND, and treatment should be based on the individual assessment rather than an assumed cause.
Is FND the same as somatic symptom disorder?
They are distinct diagnostic concepts. FND involves functional neurological symptoms established through an appropriate neurological assessment. Somatic symptom disorder in DSM-5-TR emphasizes clinically significant excessive thoughts, feelings, or behaviors related to distressing physical symptoms. An FND diagnosis does not require the person to have somatic symptom disorder.
Should new symptoms always be attributed to FND?
No. Familiar symptom recurrence may be addressed within an agreed clinical plan, while new, rapidly evolving, or medically concerning symptoms should receive appropriate reassessment. The presence of FND does not protect against other neurological or medical conditions.
Related Articles
For historical terminology and how modern clinical understanding evolved, see Conversion Neurosis: Historical Meaning and Functional Neurological Symptom Disorder. For a distinct clinical differential, see Panic Attack vs Seizure: Symptoms, Awareness, and Medical Assessment. These articles address neighboring topics; this page owns FND recovery and prognosis.
References
Aybek, S., & Perez, D. L. (2022). Diagnosis and management of functional neurological disorder. BMJ, 376, o64. https://www.bmj.com/content/376/bmj.o64
Gelauff, J. M., Stone, J., Edwards, M. J., & Carson, A. (2014). The prognosis of functional (psychogenic) motor symptoms: A systematic review. Journal of Neurology, Neurosurgery & Psychiatry, 85, 220–226. https://doi.org/10.1136/jnnp-2013-305321
Goldstein, L. H., et al. (2020). Cognitive behavioural therapy for adults with dissociative seizures (CODES): A pragmatic, multicentre, randomised controlled trial. The Lancet Psychiatry. https://pmc.ncbi.nlm.nih.gov/articles/PMC7242906/
Keatley, E. S., et al. (2026). Rehabilitation therapies for functional neurological disorder: A systematic review and meta-analysis of clinical trials. The Journal of Neuropsychiatry and Clinical Neurosciences. https://doi.org/10.1176/appi.neuropsych.20250222
Mavroudis, I., et al. (2025). Treatment of functional neurological disorder: An umbrella review of systematic reviews and meta-analyses. Journal of Neurology. https://doi.org/10.1007/s00415-025-13449-7
Mavroudis, I., Petridis, F., Franekova, K., Papagiannopoulos, S., & Kazis, D. (2026). Prognosis and outcomes in functional neurological disorder: A PRISMA-compliant systematic review with subtype-specific synthesis and clinical translation. Journal of Neurology, 273, 208. https://doi.org/10.1007/s00415-026-13748-7
Nicholson, C., et al. (2020). Occupational therapy consensus recommendations for functional neurological disorder. Journal of Neurology, Neurosurgery & Psychiatry, 91, 1037–1045. https://doi.org/10.1136/jnnp-2019-322281
Nielsen, G., et al. (2015). Physiotherapy for functional motor disorders: A consensus recommendation. Journal of Neurology, Neurosurgery & Psychiatry, 86, 1113–1119. https://doi.org/10.1136/jnnp-2014-309255
Nielsen, G., et al. (2024). Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): A pragmatic, multicentre, phase 3 randomised controlled trial. The Lancet Neurology. https://pubmed.ncbi.nlm.nih.gov/38768621/
Nielsen, G., et al. (2025). Which factors predict outcome from specialist physiotherapy for functional motor disorder? Prognostic modelling of the Physio4FMD intervention. Journal of Psychosomatic Research, 190, 112056. https://doi.org/10.1016/j.jpsychores.2025.112056
Sekine, E. R., Kanaan, R. A., McMillan, J., Oxford, S., & Iles, R. A. (2025). Biopsychosocial prognostic indicators in functional neurological disorder: A systematic review. Journal of Psychosomatic Research, 195, 112201. https://doi.org/10.1016/j.jpsychores.2025.112201
Tolchin, B., et al. (2026). Management of functional seizures practice guideline executive summary: Report of the AAN Guidelines Subcommittee. Neurology, 106, e214466. https://doi.org/10.1212/WNL.0000000000214466
Wang, A., et al. (2025). Analysis of clinical characteristics and prognosis of childhood functional neurological disorder: Identifying key factors of prognosis and optimizing clinical management. Journal of Psychosomatic Research, 192, 112120. https://doi.org/10.1016/j.jpsychores.2025.112120